American Lung Association Launches Campaign to Boost Clinical Trial…

Event summary

American Lung Association expands Awareness, Trust and Action campaign to raise clinical trial awareness for lung cancer patients.
Campaign highlights disparities in clinical trial participation among Black and Hispanic/Latino communities.
Only 1% of lung cancer clinical trial participants identify as Hispanic, raising concerns about treatment efficacy for underrepresented groups.
Genentech and Roche provide support for the campaign.
Campaign features physician advocates Italo M. Brown and Leslie Gonzalez to address misconceptions about clinical trials.

The big picture

The American Lung Association's campaign addresses a critical gap in clinical trial participation, which has historically underrepresented minority communities despite their higher lung cancer burden. This initiative aligns with broader industry efforts to improve health equity and ensure that medical advancements benefit all populations. The involvement of major pharmaceutical partners like Genentech and Roche underscores the strategic importance of this work in accelerating lung cancer research and treatment innovation.

What we're watching

Diversity in Trials: Whether the campaign can significantly increase participation rates among underrepresented communities.
Treatment Efficacy: How improved representation in clinical trials will affect the development of more effective treatments.
Campaign Impact: The pace at which awareness and trust in clinical trials grow among lung cancer patients.